William Rice
Directeur Général chez APTOSE BIOSCIENCES INC.
Fortune : 39 691 $ au 30/04/2024
Postes actifs de William Rice
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| APTOSE BIOSCIENCES INC. | Comptroller/Controller/Auditor | 07/04/2022 | - |
| Directeur Général | 28/10/2013 | - | |
| Président | 28/10/2013 | - | |
| President | 28/10/2013 | - | |
Cylene Pharmaceuticals, Inc.
 Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Président | 28/09/2010 | - |
| Directeur/Membre du Conseil | 28/09/2010 | - | |
| Directeur Général | 01/01/2003 | - | |
| President | 01/01/2003 | - |
Historique de carrière de William Rice
Anciens postes connus de William Rice
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| ONCOLYTICS BIOTECH INC. | Directeur/Membre du Conseil | 08/06/2015 | 01/01/2021 |
| Independent Dir/Board Member | 08/06/2015 | 01/01/2021 | |
| ACHILLION PHARMACEUTICALS, INC. | Directeur/Membre du Conseil | 17/08/1998 | 01/08/2003 |
| Directeur Général | 17/08/1998 | 01/08/2003 | |
| Fondateur | 17/08/1998 | 01/08/2003 | |
| President | 17/08/1998 | 01/08/2003 | |
| Frederick National Laboratory For Cancer Research | Corporate Officer/Principal | 01/01/1992 | 01/01/1998 |
| Emory University School of Medicine | Corporate Officer/Principal | 01/01/1989 | 01/01/1992 |
Formation de William Rice
| Emory University | Doctorate Degree |
Statistiques
Internationale
| Etats-Unis | 6 |
| Canada | 3 |
Opérationnelle
| Director/Board Member | 3 |
| Chief Executive Officer | 3 |
| President | 3 |
Sectorielle
| Health Technology | 5 |
| Consumer Services | 3 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| APTOSE BIOSCIENCES INC. | Health Technology |
| ONCOLYTICS BIOTECH INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Cylene Pharmaceuticals, Inc.
Cylene Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cylene Pharmaceuticals, Inc. discovers, develops and commercializes small molecule drugs. It develops molecule drugs to treat life-threatening diseases, with a particular emphasis in oncology. The firm drug discovery platform, STAND has delivered a diverse portfolio of drug candidates that target the multiple pathways critical for the support, maintenance of cancer cells and that address unmet medical needs with substantial markets. The company was founded in 1997 by Thomas James Farrell and Daniel Douglas Von Hoff and is headquartered in San Diego, CA. | Health Technology |
Achillion Pharmaceuticals, Inc.
 Achillion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Achillion Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of oral small molecule complement system inhibitors. Its pipeline includes Danicopan and ACH-5228. The company was founded on August 17, 1998 and is headquartered in Blue Bell, PA. | Health Technology |
| Frederick National Laboratory For Cancer Research |
- Bourse
- Insiders
- William Rice
- Expérience
